drugset / Trial / NCT04602104
A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate allogeneic human mesenchymal stem cell exosomes (hMSC-Exos) in the treatment of acute respiratory distress syndrome (ARDS)
Timeline
- Start
- 2020-11-30
- Primary completion
- 2022-11-10
- Completion
- 2023-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hMSC-Exos | Other / unclassified | 2e+08 unknown | Inhaled |
| Subject | hMSC-Exos | Other / unclassified | 8e+08 unknown | Inhaled |
| Subject | hMSC-Exos | Other / unclassified | 1.6e+09 unknown | Inhaled |